How long a patient can live in the middle and late stages of liver cancer cannot be generalized, but it mainly depends on the patient’s specific condition and the subsequent treatment, which needs specific analysis. Overall, the prognosis of treatment for patients with intermediate and advanced liver cancer is relatively poor. It is difficult for these patients to completely remove the tumor through local treatment such as surgery, and without treatment, the expected survival time is 3-6 months, but the exact time varies from person to person. With the current medical level, for patients with mid to late stage liver cancer without obvious comorbidities, an average survival time of about 2 years can be achieved through standardized treatment. Liver cancer is a relatively aggressive disease, and when it is in the middle and late stage, it indicates that the disease is developing faster or has metastasized or spread. Patients can help control the disease and prolong the survival through comprehensive treatment, such as interventional, targeted, immunotherapy, chemotherapy and so on. However, patients with very advanced liver cancer, once jaundice, ascites, vomiting blood and other symptoms appear, generally expect a short survival time and have difficulty in receiving anti-tumor treatment.